Study of PSP has led to conflicting results, with some studies showing a lack of atrophy in the prefrontal cortex,46,47 whilst others confirmed its presence.48-50 Our study used cases that were neuropathologically diagnosed as PSP with clinical FTD but nevertheless had relatively little tau pathology or cerebral cortical degeneration. The gene discussed is MAPT; the disease is frontotemporal dementia.